Fingerprint
Dive into the research topics of 'First-line doublet chemotherapy for metastatic triple-negative breast cancer: Circulating tumor cell analysis of the tnAcity trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
First-line doublet chemotherapy for metastatic triple-negative breast cancer: Circulating tumor cell analysis of the tnAcity trial
Minetta C. Liu, Wolfgang Janni, Vassilis Georgoulias, Denise A. Yardley, Nadia Harbeck, Xin Wei, Desmond McGovern, Robert Beck
Research output: Contribution to journal › Article › peer-review
2
Scopus
citations